Relapsed, Refractory Melanoma
1 clinical trials · Condition
◉ Watch Relapsed, Refractory Melanoma
| Record | Firm | Date |
|---|---|---|
| RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER (NCT02029729) | Biogen | 2013-12-31 |
Track Relapsed, Refractory Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.